Vitamin D alone, in the absence of a demonstrable deficiency, is barely effective against bone loss. The combination with calcium offers a modest but measurable benefit for bone density and hip fracture risk, provided an actual vitamin D deficiency is present (blood level below 32 ng/mL). For people with established osteoporosis, proven medications such as bisphosphonates are the cornerstone of treatment; supplementation plays a supportive role within that framework.
Vitamin D as a standalone supplement, without calcium, has virtually no demonstrable effect on bone density. A large meta-analysis of 23 studies involving more than 4,000 participants found only a small statistical benefit at the femoral neck (hip bone, +0.8%), but at all other measured sites there was no effect. The researchers conclude that the broad use of vitamin D as a bone supplement in people without a demonstrable deficiency is not supported by the evidence1.
The combination of calcium and vitamin D produces a better result than vitamin D alone. A meta-analysis in postmenopausal women showed that the combination significantly increases bone density at multiple sites and reduces the risk of hip fractures by approximately 14%2. An important caveat: this benefit was found primarily for dairy products fortified with both substances, not convincingly for standalone pills. Furthermore, at higher doses of vitamin D exceeding 400 IU per day, no additional benefit was found at the femoral neck.
Supplementation is most useful when an actual vitamin D deficiency is present. Research shows that a blood level of at least 32 ng/mL is needed for optimal protection against fractures and adequate calcium absorption from the gut. A large proportion of the population, particularly people with darker skin, falls well below this threshold3. If blood levels are already adequate, the gain from additional supplementation is smaller.
For people who are already using medication for osteoporosis, such as bisphosphonates, a systematic review of 37 studies (more than 43,000 patients) shows that adding vitamin D is associated with fewer gastrointestinal side effects and lower mortality. Calcium showed no clear additional benefit on bone density or fractures in that context4. Vitamin D and calcium are considered supportive alongside the medication, not as a replacement for it.
Medications such as bisphosphonates and denosumab are by far the most strongly supported for reducing fractures in established osteoporosis, according to clinical guidelines5. Calcium and vitamin D are used alongside these as supplements. A small randomised study in 120 women showed that intensive interval exercise combined with vitamin D supplementation (800 IU per day) produced greater improvements in bone density than either intervention alone, but this study is too small and too limited to form the basis of broad recommendations6. A review article additionally emphasises that fall prevention and addressing physical frailty in older adults also contribute to preventing fractures, alongside nutritional supplements7.
The claims are based on multiple meta-analyses and systematic reviews with large numbers of participants, supplemented by a small RCT and a review article. The evidence base is strongest for 'vitamin D alone has little effect' and 'medications work best'. The calcium and vitamin D combination has moderate evidence for a modest benefit, with caveats around the form of administration and dosage.